Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-08-13 19:18:32 UTC |
---|
Update Date | 2023-02-21 17:17:02 UTC |
---|
HMDB ID | HMDB0004461 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Benzamide |
---|
Description | Benzamide, also known as PHC(=o)NH2 or phenylcarboxamide, belongs to the class of organic compounds known as benzamides. These are organic compounds containing a carboxamido substituent attached to a benzene ring. Benzamide exists in all living organisms, ranging from bacteria to humans. Benzamide is a bitter tasting compound. Benzamide has been detected, but not quantified in, a few different foods, such as anatidaes (Anatidae), chickens (Gallus gallus), and domestic pigs (Sus scrofa domestica). This could make benzamide a potential biomarker for the consumption of these foods. Benzamide is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a significant number of articles have been published on Benzamide. |
---|
Structure | InChI=1S/C7H7NO/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H2,8,9) |
---|
Synonyms | Value | Source |
---|
Benzenecarboxamide | ChEBI | Benzoic acid amide | ChEBI | Benzoylamide | ChEBI | PHC(=O)NH2 | ChEBI | PHC(O)NH2 | ChEBI | Phenylcarboxamide | ChEBI | Phenylcarboxyamide | ChEBI | Benzoate amide | Generator | Amid kyseliny benzoove | HMDB | Benzamide (acd/name 4.0) | HMDB | Benzoate | HMDB | Benzoic acid | HMDB | Phenyl carboxyamide | HMDB | Tigan | HMDB | Trimethobenzamide hydrochloride | HMDB |
|
---|
Chemical Formula | C7H7NO |
---|
Average Molecular Weight | 121.1366 |
---|
Monoisotopic Molecular Weight | 121.052763851 |
---|
IUPAC Name | benzamide |
---|
Traditional Name | benzamide |
---|
CAS Registry Number | 55-21-0 |
---|
SMILES | NC(=O)C1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C7H7NO/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H2,8,9) |
---|
InChI Key | KXDAEFPNCMNJSK-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzamides. These are organic compounds containing a carboxamido substituent attached to a benzene ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Benzoic acids and derivatives |
---|
Direct Parent | Benzamides |
---|
Alternative Parents | |
---|
Substituents | - Benzamide
- Benzoyl
- Primary carboxylic acid amide
- Carboxamide group
- Carboxylic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | |
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Benzamide,1TMS,isomer #1 | C[Si](C)(C)NC(=O)C1=CC=CC=C1 | 1406.7 | Semi standard non polar | 33892256 | Benzamide,1TMS,isomer #1 | C[Si](C)(C)NC(=O)C1=CC=CC=C1 | 1441.8 | Standard non polar | 33892256 | Benzamide,1TMS,isomer #1 | C[Si](C)(C)NC(=O)C1=CC=CC=C1 | 1665.3 | Standard polar | 33892256 | Benzamide,2TMS,isomer #1 | C[Si](C)(C)N(C(=O)C1=CC=CC=C1)[Si](C)(C)C | 1483.9 | Semi standard non polar | 33892256 | Benzamide,2TMS,isomer #1 | C[Si](C)(C)N(C(=O)C1=CC=CC=C1)[Si](C)(C)C | 1522.4 | Standard non polar | 33892256 | Benzamide,2TMS,isomer #1 | C[Si](C)(C)N(C(=O)C1=CC=CC=C1)[Si](C)(C)C | 1652.6 | Standard polar | 33892256 | Benzamide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)C1=CC=CC=C1 | 1637.0 | Semi standard non polar | 33892256 | Benzamide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)C1=CC=CC=C1 | 1608.4 | Standard non polar | 33892256 | Benzamide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)C1=CC=CC=C1 | 1834.9 | Standard polar | 33892256 | Benzamide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 1910.4 | Semi standard non polar | 33892256 | Benzamide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 1918.1 | Standard non polar | 33892256 | Benzamide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 1902.7 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Benzamide EI-B (Non-derivatized) | splash10-0ab9-2900000000-d10a8514e7c0dedd5758 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Benzamide EI-B (Non-derivatized) | splash10-0kk9-8900000000-a6264ed866860ca71f94 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Benzamide EI-B (Non-derivatized) | splash10-0adi-7900000000-c79bab8ceedf3b276ae1 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Benzamide GC-EI-TOF (Non-derivatized) | splash10-0fbi-0900000000-e11c600f209e5f1be1fd | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Benzamide EI-B (Non-derivatized) | splash10-0ab9-2900000000-d10a8514e7c0dedd5758 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Benzamide EI-B (Non-derivatized) | splash10-0kk9-8900000000-a6264ed866860ca71f94 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Benzamide EI-B (Non-derivatized) | splash10-0adi-7900000000-c79bab8ceedf3b276ae1 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Benzamide GC-EI-TOF (Non-derivatized) | splash10-0fbi-0900000000-e11c600f209e5f1be1fd | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Benzamide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0pi0-4900000000-24e0b6bee128508783c3 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Benzamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Benzamide Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-00fr-3900000000-274cc52f0c0c8accad8c | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Benzamide Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-0fb9-9400000000-53a105851fb3f3bfa447 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Benzamide Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-0fb9-9000000000-3fd0ac2c3e583778d4f7 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Benzamide EI-B (HITACHI M-80) , Positive-QTOF | splash10-0ab9-2900000000-d10a8514e7c0dedd5758 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Benzamide EI-B (HITACHI RMU-7M) , Positive-QTOF | splash10-0kk9-8900000000-6e34f51843ee9cdd8237 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Benzamide LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive-QTOF | splash10-00di-1900000000-b21069169eafde58c822 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Benzamide LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive-QTOF | splash10-0a6r-8900000000-85f7934fa93d7240804f | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Benzamide LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive-QTOF | splash10-004i-9200000000-e4b0272643ae9f111021 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Benzamide LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive-QTOF | splash10-004i-9100000000-c34f0e594deb730ca6b7 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Benzamide LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive-QTOF | splash10-0fb9-9100000000-76a5adf911f1a97ad45b | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Benzamide LC-ESI-QQ , positive-QTOF | splash10-00di-1900000000-c6e30a6a9805ba36fc2a | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Benzamide LC-ESI-QQ , positive-QTOF | splash10-0a6r-8900000000-d40d6a968a8a706e6500 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Benzamide LC-ESI-QQ , positive-QTOF | splash10-004i-9200000000-e4b0272643ae9f111021 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Benzamide LC-ESI-QQ , positive-QTOF | splash10-004i-9100000000-c34f0e594deb730ca6b7 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Benzamide LC-ESI-QQ , positive-QTOF | splash10-0fb9-9100000000-76a5adf911f1a97ad45b | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Benzamide LC-ESI-QFT , positive-QTOF | splash10-05i0-3900000000-105f114ff019238e0401 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Benzamide 35V, Positive-QTOF | splash10-004l-9200000000-8469324285df124d1be3 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Benzamide 35V, Positive-QTOF | splash10-05i0-3900000000-d11c117a49a854420bb8 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzamide 10V, Positive-QTOF | splash10-00di-0900000000-b10777bbfb9e15c822c0 | 2015-04-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzamide 20V, Positive-QTOF | splash10-00di-4900000000-4401050524c9108d0e36 | 2015-04-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzamide 40V, Positive-QTOF | splash10-0udi-9600000000-a2aca9e73b19fc5335b3 | 2015-04-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzamide 10V, Negative-QTOF | splash10-00di-1900000000-cb7510152a09599b3704 | 2015-04-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzamide 20V, Negative-QTOF | splash10-00fr-6900000000-4e21f69e91793514c49e | 2015-04-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzamide 40V, Negative-QTOF | splash10-0006-9000000000-a5e23c6893e288e53794 | 2015-04-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzamide 10V, Positive-QTOF | splash10-05fr-1900000000-2bb0f9ac1f4add8c0853 | 2021-09-23 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
General References | - Chemnitius JM, Haselmeyer KH, Gonska BD, Kreuzer H, Zech R: Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood. Pharmacol Res. 1996 Jul-Aug;34(1-2):65-72. [PubMed:8981558 ]
- Coyle JD, MacKichan JJ, Boudoulas H, Lima JJ: Reversed-phase liquid chromatography method for measurement of procainamide and three metabolites in serum and urine: percent of dose excreted as deethyl metabolites. J Pharm Sci. 1987 May;76(5):402-5. [PubMed:2443639 ]
- Chiba R, Ogasawara A, Kubo T, Yamazaki H, Umino M, Ishizuka Y: Direct determination of benzamides in serum by column-switching high-performance liquid chromatography. Anal Sci. 2003 May;19(5):785-9. [PubMed:12769385 ]
- Yamamoto T, Hanioka N, Maeda Y, Imazumi K, Hamada K, Matsuo M, Manda T, Mutoh S: Contribution of tachykinin receptor subtypes to micturition reflex in guinea pigs. Eur J Pharmacol. 2003 Sep 23;477(3):253-9. [PubMed:14522364 ]
- Gschwend MH, Arnold P, Ring J, Martin W: Selective and sensitive determination of amisulpride in human plasma by liquid chromatography-tandem mass spectrometry with positive electrospray ionisation and multiple reaction monitoring. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Feb 2;831(1-2):132-9. Epub 2005 Dec 28. [PubMed:16386474 ]
- de Jong AP, Wittebrood AJ, du Chatinier WM, Bron J: Liquid chromatographic analysis of alizapride and metoclopramide in human plasma and urine using solid-phase extraction. J Chromatogr. 1987 Aug 7;419:233-42. [PubMed:3667781 ]
- Jitsufuchi N, Kudo K, Tokunaga H, Imamura T: Selective determination of sultopride in human plasma using high-performance liquid chromatography with ultraviolet detection and particle beam mass spectrometry. J Chromatogr B Biomed Sci Appl. 1997 Mar 7;690(1-2):153-9. [PubMed:9106039 ]
- Delarue C, Contesse V, Lefebvre H, Lenglet S, Grumolato L, Kuhn JM, Vaudry H: Pharmacological profile of serotonergic receptors in the adrenal gland. Endocr Res. 1998 Aug-Nov;24(3-4):687-94. [PubMed:9888560 ]
|
---|